CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

CVS Health Corporation

In a report released yesterday, Alexander Paris from Barrington reiterated a Buy rating on Covista, with a price target of $170.00. According to Ti...

Barrington Sticks to Their Buy Rating for Covista (CVSA)

Bernstein analyst Lance Wilkes maintained a Buy rating on CVS Health today and set a price target of $106.00. Wilkes covers the Healthcare sector, ...

Bernstein Remains a Buy on CVS Health (CVS)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Senseonics Holdings (SENS) and CVS Health (CVS) with...

Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and CVS Health (CVS)

CVS Group plc ( ($GB:CVSG) ) has shared an update. CVS Group plc, a major veterinary services provider in the UK and Australia, focuses on deliveri...

CVS Group Cuts Share Count with Completion of Initial Buyback Tranche

An update from CVS Group plc ( ($GB:CVSG) ) is now available. CVS Group plc, a major veterinary services provider with over 475 practices across th...

CVS Group cancels 222,000 shares in ongoing buyback

CV Sciences ( ($CVSI) ) has shared an update. On June 2, 2026, CV Sciences, Inc. held its 2026 Annual Meeting of Stockholders in virtual format, wi...

CV Sciences Shareholders Elect Directors, Reject Reverse Stock Split

Retail investors are scurrying away from pet group Chewy ($CHWY) as it gets set to release Q1 earnings next week – June 10. Chewy, whose stock is d...

Retail Investors Fear Chewy Stock (CHWY) is a Dog Ahead of Q1 Earnings

Analysts have been eager to weigh in on the Healthcare sector with new ratings on CVS Health (CVS), Revolution Medicines (RVMD) and Neumora Therape...

Analysts Conflicted on These Healthcare Names: CVS Health (CVS), Revolution Medicines (RVMD) and Neumora Therapeutics, Inc. (NMRA)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CVS Health (CVS), Dexcom (DXCM) and HCA Healthcare (...

Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), Dexcom (DXCM) and HCA Healthcare (HCA)

In a report released today, from Berenberg Bank reiterated a Buy rating on CVS Group plc, with a price target of p2,000.00. The word on The Street ...

Berenberg Bank Keeps Their Buy Rating on CVS Group plc (CVSG)

Insiders have been trading these 5 stocks: (($RIVN)), (($CVS)), (($NOW)), (($DKNG)) and (($AMC)). Here is a breakdown of their recent trades and th...

Current Quarter	$1.85	Next Quarter	$1.71
Current Year	$7.44	Next Year	$8.37
QoQ Growth	-7.6%	YoY Growth	+12.5%
3Y EPS CAGR	-23.8%	Target Price	$103.87
Consensus	Buy	Upside	+5.6%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CVS	$98.32	-0.85%	21.58M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CVS	$98.32	-0.8%	21.58M
3
4
5
6

CVS

CVS

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get CVS Health Corporation Data in Excel

Get CVS Health Corporation Data in Excel